Camena Bioscience

Camena Bioscience is a biotechnology startup with a mission to enable synthetic biologists by unlocking access to genes with unparalleled accuracy. The company, founded in 2016 and headquartered in Cambridge, UK, serves a range of biotechnology customers including those in the pharmaceutical, agriculture, and diagnostics sectors. Its innovative technology facilitates access to long and complex gene sequences, addressing a common challenge in gene production. Camena's technology has garnered significant attention, attracting a £7.90M Series A investment on 03 July 2023 from Mercia Asset Management. This investment underscores the confidence of investors in Camena's potential to transform the biotechnology and healthcare industries. As the company continues to expand its reach, it is positioned to play a pivotal role in advancing the field of synthetic biology. Follow Camena Bioscience on Twitter: @camenabio.